We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current BLSIF market cap is 0. The company's latest EPS is CAD and P/E is N/A.
| Year End March 30 2023 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 197k | 974k | 32k | 7.3M | 6.4M |
| Operating Income | -11.4M | -5.41M | -1.62M | 1.86M | 1.16M |
| Net Income | -11.86M | -7.13M | -3.2M | -15.46M | 5.84M |
| Year End March 30 2023 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 5.65M | 3.16M | 257k | 21.09M | 23.55M |
| Total Liabilities | 9.14M | 13.24M | 13.46M | 15.61M | 12.49M |
| Total Equity | -3.49M | -10.08M | -13.2M | 5.48M | 11.06M |
| Year End March 30 2023 | 2018 | 2019 | 2020 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.98M | -7.11M | -208k | 2.8M | 1.22M |
| Investing | -544k | -68k | N/A | 654k | -3.32M |
| Financing | 7.32M | 3.55M | 23k | -2.58M | 2.95M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 162.25M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Britannia Life Sciences Inc (PK) |
| Address |
120 adelaide street west,suite 2400 toronto, ontario M5H 1T1 |
| Website | https://www.britannia.life |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
